Foreign
TO date, 45 kinds of orphan drugs have been included in China’s national medical insurance catalog, as the country ramps up efforts to increase drug affordability for patients of rare diseases.
These orphan drugs are used in the treatment of 26 rare diseases, according to data released at the ongoing 2022 China Conference on Rare Diseases in Beijing.
Since 2018, 19 new orphan drugs had been added to the national medical insurance catalogue, with an average price reduction of 52.6 per cent.
There are more than 20 million patients with various types of rare diseases in China, with the number increasing by over 200,000 yearly, said the data. (Xinhua/NAN)
KN
Tags: China Conference on Rare Diseases in BeijingRelated Posts
Most Read
EducationABU International Studies Alumni offers scholarships to 20 indigent students By editor1 MIN READ
AfricaEnergy Industry Congratulates John Mahama on Re-election, Commends Progress in Oil and Gas SectorBy editor1 MIN READ
BusinessAFAWA initiative teams with African Guarantee Fund, Bank of Industry for $50m financing agreement targeting Nigerian small and medium enterprisesBy editor1 MIN READ
BusinessAfreximbank participates in Bank of Industry Nigeria’s syndicated facility of up to EUR 2-billionBy editor1 MIN READ
